Raymond James & Associates’s Ardelyx ARDX Stock Holding History
Bought
Maintained
Sold
Other funds holding ARDX
EAM
RCMNY
Raymond James & Associates's ARDX Position: Q3 2024 in Review
Raymond James & Associates increased its Ardelyx (ARDX) stake by 6.5% in Q3 2024, buying an estimated $7.69K and bringing the position to 21,515 shares worth $148K. The position accounts for ﹤0.01% of the portfolio, ranked #3718.
Raymond James & Associates first reported a position in ARDX in Q4 2023 and has held it in 4 quarters since. The position peaked at $150K in Q2 2024. 203 funds tracked by Wall St. Rank hold ARDX as of Q3 2024.
- Raymond James & Associates held 21,515 shares of Ardelyx worth $148K as of Q3 2024.
- Raymond James & Associates bought 1,304 Ardelyx shares in Q3 2024, an estimated $7.69K.
- Ardelyx made up ﹤0.01% of Raymond James & Associates's portfolio in Q3 2024, its #3718 holding.
- Raymond James & Associates first reported a position in Ardelyx in Q4 2023 and has held it in 4 quarters since.
- Raymond James & Associates's Ardelyx position peaked at $150K in Q2 2024.
- 203 funds tracked by Wall St. Rank held Ardelyx as of Q3 2024.
Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.